-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 27/03/26 )
NAV
₹107.02
Last change
₹-1.02 -0.01%
Fund Size (AUM)
8306.35 Cr
Performance
15.78% (5Y)
Fund Details
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 27/03/26
AUM
8306.35 Cr
Expense Ratio
1.81 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl | 2.27% | 21.73% | 15.78% |
| BSE Healthcare TR INR | 14.93% | 26.68% | 16.06% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.08% |
Lupin Ltd |
7.99% |
Divi's Laboratories Ltd |
6.56% |
Dr Reddy's Laboratories Ltd |
5.81% |
Cipla Ltd |
5.67% |
Apollo Hospitals Enterprise Ltd |
5.17% |
Medplus Health Services Ltd |
3.7% |
Max Healthcare Institute Ltd Ordinary Shares |
3.49% |
Vijaya Diagnostic Centre Ltd |
3.49% |
Ajanta Pharma Ltd |
3.41% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
100%
Equity
-
0%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Fund
Equity healthcare-
Returns
-
17.09% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R Fund
Equity healthcare-
Returns
-
16.42% (5Y)
-
-
SBI Healthcare Opportunities Fund
Equity healthcare-
Returns
-
17.33% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R Fund
Equity healthcare-
Returns
-
17.33% (5Y)
-
-
UTI Healthcare Fund
Equity healthcare-
Returns
-
15.14% (5Y)
-
-
UTI Healthcare IDCW-P Fund
Equity healthcare-
Returns
-
15.14% (5Y)
-
